What is an important consideration when using topical CA inhibitors in patients with a sulfa allergy?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Prepare for the Ophthalmic Medications Test with flashcards and multiple choice questions. Each question includes hints and explanations to enhance your understanding. Gear up for your exam!

Multiple Choice

What is an important consideration when using topical CA inhibitors in patients with a sulfa allergy?

Explanation:
Topical carbonic anhydrase inhibitors, such as dorzolamide and brinzolamide, contain a sulfonamide group, so patients with sulfa allergy have a potential risk of a sulfonamide-type allergic reaction to these drops. Because of this, the cautious approach is to avoid or closely monitor and be ready to switch to alternatives if any allergic reaction occurs. If needed, choose glaucoma medications from other classes that do not involve sulfonamide structures, such as prostaglandin analogs (latanoprost, bimatoprost) or non-sulfa agents like beta-blockers (timolol) or alpha-2 agonists (brimonidine).

Topical carbonic anhydrase inhibitors, such as dorzolamide and brinzolamide, contain a sulfonamide group, so patients with sulfa allergy have a potential risk of a sulfonamide-type allergic reaction to these drops. Because of this, the cautious approach is to avoid or closely monitor and be ready to switch to alternatives if any allergic reaction occurs. If needed, choose glaucoma medications from other classes that do not involve sulfonamide structures, such as prostaglandin analogs (latanoprost, bimatoprost) or non-sulfa agents like beta-blockers (timolol) or alpha-2 agonists (brimonidine).

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy